Does İsotretinoin (ISO) Therapy İncrease Coagulation Tendency? Evaluation of MPV values and MPV / platelet rate

---

Author Details : Pinar Ozuguz, M. Sena Ulu, Seval Dogruk Kacar, Ufuk Ozuguz, Semsettin Karaca

Volume : 1, Issue : 1, Year : 2015

Article Page : 14-16

Suggest article by email

Get Permission

---

Abstract

Introduction/ Purpose: Mean Platelet Volume (MPV), an indicator of platelet activation, is a new risk factor for atherothrombosis and an important marker for the increase in thromboembolic diseases. MPV/ platelet ratio is considered as a risk factor for various diseases such as myocardial infarction. In this study, we aimed to investigate the possible effect of ISO on blood cell counts especially MPV and MPV/ platelet ratio.
Materials and Methods: 75 patients, between the ages of 18-25 with moderate or severe acne vulgaris and using oral isotretinoin (0.5 mg/ kg) were included in the study. Platelet count ​​and MPV values of patients (pre-treatment and 3 months after the treatment) were recorded retrospectively.
Results: The mean age of patients was 23.32+3.44 years. 40 patients were female and 35 were male. MPV levels and MPV/ p ratio of “before treatment period” were significantly higher than the “after treatment period” (p Conclusion: In the literature, alteration in platelet levels under ISO treatment is a controversial issue. Furthermore, it was emphasized that, ISO treatment may be change platelet functions. In our study, MPV values and MPV / p ratio were decreased after ISO treatment. Our data indicates that, the thromboembolic risk of patients with acne vulgaris may reduce after ISO treatment.

Keywords: Acne vulgaris, İsotretinoin, MPV, Platelet,  Thromboembolism risk

How to cite : Ozuguz P, Ulu M S, Kacar S D, Ozuguz U, Karaca S, Does İsotretinoin (ISO) Therapy İncrease Coagulation Tendency? Evaluation of MPV values and MPV / platelet rate. IP Indian J Clin Exp Dermatol 2015;1(1):14-16

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.